Literature DB >> 9732413

Prenatal exposure to fluoxetine (Prozac) produces site-specific and age-dependent alterations in brain serotonin transporters in rat progeny: evidence from autoradiographic studies.

T M Cabrera-Vera1, G Battaglia.   

Abstract

The present study provides the first autoradiographic evidence of age-dependent regional changes in the density of serotonin (5-HT) transporters in offspring following prenatal exposure to fluoxetine. Pregnant rats received either saline or fluoxetine (10 mg/kg, s.c.) daily from gestational day 13 through 20. The density of [3H]citalopram-labeled 5-HT transporters was determined in forebrain regions and in midbrain raphe nuclei of prepubescent and adult male offspring. Brain regions representing integral components of the limbic system were particularly sensitive to the prenatal treatment. For example, prenatal fluoxetine exposure significantly altered the density of 5-HT transporters in subregions of the hypothalamus (dorsomedial nucleus, -21%; lateral hypothalamus, +21%), hippocampus (CA2, +47%; CA3, +38%), and amygdala (basolateral nucleus, +32%; medial nucleus, +44%) in prepubescent offspring. However, 5-HT transporter density in the dorsal and median raphe was unaltered in this same group of offspring. In adult offspring, 5-HT transporter densities, in all brain regions examined, were not significantly altered by prenatal exposure to fluoxetine. The present study also identifies significant age-related differences in 5-HT transporter densities between prepubescent and adult control offspring. For example, in adult control offspring, densities of 5-HT transporters were significantly greater in the cingulate cortex (+33%), basolateral amygdala (+58%), and CA1 area of the hippocampus (+78%); but significantly lower in the temporal cortex (-65%) and median raphe (-25%). The age-dependent and site-specific alterations in the density of 5-HT transporters suggests that either 5-HT innervation and/or 5-HT neuron function in various forebrain regions may be altered by prenatal exposure to fluoxetine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9732413

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  15 in total

1.  Antidepressant use during pregnancy.

Authors:  P Boksa
Journal:  J Psychiatry Neurosci       Date:  2001-01       Impact factor: 6.186

2.  Prenatal exposure to escitalopram and/or stress in rats: a prenatal stress model of maternal depression and its treatment.

Authors:  Chase H Bourke; Catherine F Capello; Swati M Rogers; Megan L Yu; Katherine A Boss-Williams; Jay M Weiss; Zachary N Stowe; Michael J Owens
Journal:  Psychopharmacology (Berl)       Date:  2013-02-24       Impact factor: 4.530

Review 3.  Prenatal antidepressant exposure: clinical and preclinical findings.

Authors:  Chase H Bourke; Zachary N Stowe; Michael J Owens
Journal:  Pharmacol Rev       Date:  2014-02-24       Impact factor: 25.468

4.  Prenatal stress, regardless of concurrent escitalopram treatment, alters behavior and amygdala gene expression of adolescent female rats.

Authors:  David E Ehrlich; Gretchen N Neigh; Chase H Bourke; Christina L Nemeth; Rimi Hazra; Steven J Ryan; Sydney Rowson; Nesha Jairam; Courtney A Sholar; Donald G Rainnie; Zachary N Stowe; Michael J Owens
Journal:  Neuropharmacology       Date:  2015-05-30       Impact factor: 5.250

Review 5.  Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.

Authors:  Lynette C Daws; Georgianna G Gould
Journal:  Pharmacol Ther       Date:  2011-04-05       Impact factor: 12.310

6.  The effects of perinatal fluoxetine treatment on the circadian system of the adult mouse.

Authors:  Veronika Kiryanova; Victoria M Smith; Richard H Dyck; Michael C Antle
Journal:  Psychopharmacology (Berl)       Date:  2012-09-13       Impact factor: 4.530

7.  Prenatal exposure to escitalopram and/or stress in rats produces limited effects on endocrine, behavioral, or gene expression measures in adult male rats.

Authors:  Chase H Bourke; Zachary N Stowe; Gretchen N Neigh; Darin E Olson; Michael J Owens
Journal:  Neurotoxicol Teratol       Date:  2013-07-30       Impact factor: 3.763

8.  Serotonin transporter occupancy in rats exposed to serotonin reuptake inhibitors in utero or via breast milk.

Authors:  Catherine F Capello; Chase H Bourke; James C Ritchie; Zachary N Stowe; D Jeffrey Newport; Amanda Nemeroff; Michael J Owens
Journal:  J Pharmacol Exp Ther       Date:  2011-07-20       Impact factor: 4.030

9.  Circadian behavior of adult mice exposed to stress and fluoxetine during development.

Authors:  Veronika Kiryanova; Victoria M Smith; Richard H Dyck; Michael C Antle
Journal:  Psychopharmacology (Berl)       Date:  2016-12-27       Impact factor: 4.530

10.  Long-term effects of fluoxetine or vehicle administration during pregnancy on behavioral outcomes in guinea pig offspring.

Authors:  Raphael Vartazarmian; Saima Malik; Glen B Baker; Patricia Boksa
Journal:  Psychopharmacology (Berl)       Date:  2004-09-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.